Denali Therapeutics Inc. DNLI Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s operating lease ROU assets?
- Denali Therapeutics Inc. (DNLI) reported operating lease ROU assets of $17.92M in Q1 2026.
- How has Denali Therapeutics Inc.'s operating lease ROU assets changed year-over-year?
- Denali Therapeutics Inc.'s operating lease ROU assets increased by 19913333233.3% year-over-year, from $0.09 to $17.92M.
- What is the long-term trend for Denali Therapeutics Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s operating lease ROU assets has grown at a -10.2% compound annual growth rate (CAGR), from $32.62M to $19M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.